Saris­sa and Alex Den­ner lose fight for board seats at Alk­er­mes

Saris­sa Cap­i­tal Man­age­ment’s three nom­i­nees to the Alk­er­mes board failed to gain enough votes at a share­hold­er meet­ing, and all sev­en of the com­pa­ny’s board nom­i­nees were in­stead re-elect­ed on Thurs­day.

Saris­sa, which owns a stake in the Dublin-based bio­phar­ma, had pro­posed putting its leader Alex Den­ner, its pres­i­dent Patrice Bon­figlio and Sarah Schlesinger, an im­mu­nol­o­gist and chair of Rock­e­feller Uni­ver­si­ty’s in­sti­tu­tion­al re­view board, on the Alk­er­mes board — ar­gu­ing ear­li­er this month the cur­rent board has lit­tle over­sight and isn’t ac­count­able to share­hold­ers.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER